Abstract
Introduction/Background*The aim of the present study was to assess the impact of postponed screening examinations and lockdown measures on gynecological and breast cancer detection rate throughout the year 2020 in...
Highlights
Conducted an audit, examined the uterine cancer cases discussed in MDTs retrospectively over the period of nov 2020 to march 2021 .Cases which were reviewed are endometrial endometriod cancer (FIGO stage 1) and cases of fibroid uterus discussed due to suspicion of uterine sarcomas
Of Fibroid uterus cases, 84% turned out to be benign and 15% malignancies.MDT discussion could not contribute to the sarcomas as radiologically degenerating fibroids vs sarcoma decision was inconclusive leading to standard laparotomy and debulking decision, after ruling out extra uterine disease
Cancer patients are a unique population in that they are vulnerable to COVID-19, if immunocompromised, and their oncologic outcome is based on the type and timing of the treatment
Summary
In total 63 EEC and 18 fibroid uterus cases were discussed in 21 MDT meetings over 5 months. Regular audit will be conducted of cases not discussed in relation to the appropriateness of patients receiving a SoC and their outcome on the following grounds- How is streamlining impacting on time for those patient cases which require discussion?
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
